Document is current
Any future updates will be listed below
-
Authors
Pallett, Scott J. C. https://orcid.org/0000-0002-9465-5299
Tasker, Alex https://orcid.org/0000-0003-3836-6078
Chambers, Danny
Corley, Michael
O’Shea, Matthew K.
Davies, Sally
Moore, Luke S. P.
- License Information
-
More Information
Article History
First Online: 18 June 2025
Competing interests
: L.S.P.M. has consulted for or received speaker fees from bioMerieux (2013-2025), Eumedica (2016–2025), Pfizer (2018–2025), Sumitovant (2021–2023), Shionogi (2021–2025), Qiagen (2023), Gilead (2024), BioNTech (2024), Insmed (2024) and Advanz (2024–2025) and received research grants from the National Institute for Health and Care Research (2013–2025), CW+ Charity (2018–2025), North West London Pathology (2022–2024), LifeArc (2020–2022), Shionogi (2024–2025), Infectopharm (2022–2024), the Joint Programming Initiative on AntiMicrobial Resistance (2023–2025) and the Healthcare Infection Society (2024–2025). S.J.C.P. has received research grants from the Drummond Foundation and the John Muir Trust and Healthcare Infection Society not in connection with this work. S.J.C.P. was a parliamentary intern to the office of Dr. Danny Chambers, MP, on behalf of the British Society for Antimicrobial Chemotherapy.
